A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
The company was cleared to begin a Phase I/II trial of its lead candidate, a therapeutic vaccine that can potentially treat and prevent recurrence of KRAS-mutated cancers.
Medicare patients on FDA-approved cancer treatments in the real world do not live as long as patients in pivotal clinical trials, according to an MSK analysis.
